306 related articles for article (PubMed ID: 21592182)
1. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab.
Stephenson SR; Campbell SM; Drew GS; Magro CM
J Cutan Pathol; 2011 Aug; 38(8):644-8. PubMed ID: 21592182
[TBL] [Abstract][Full Text] [Related]
2. Palisaded neutrophilic and granulomatous dermatitis associated with ankylosing spondylitis.
de Unamuno Bustos B; Rabasco AG; Sánchez RB; de Miquel VA
Am J Dermatopathol; 2013 Dec; 35(8):847-50. PubMed ID: 23974221
[TBL] [Abstract][Full Text] [Related]
3. Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab.
Umezawa Y; Ito K; Nakagawa H
Eur J Dermatol; 2013; 23(6):910-1. PubMed ID: 24201093
[No Abstract] [Full Text] [Related]
4. Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders.
Bremner R; Simpson E; White CR; Morrison L; Deodhar A
Semin Arthritis Rheum; 2004 Dec; 34(3):610-6. PubMed ID: 15609265
[TBL] [Abstract][Full Text] [Related]
5. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis.
Sangueza OP; Caudell MD; Mengesha YM; Davis LS; Barnes CJ; Griffin JE; Fleischer AB; Jorizzo JL
J Am Acad Dermatol; 2002 Aug; 47(2):251-7. PubMed ID: 12140472
[TBL] [Abstract][Full Text] [Related]
6. Palisaded neutrophilic and granulomatous dermatitis in a patient with rheumatoid arthritis.
Cardenas-de la Garza JA; Arvizu-Rivera RI; Skinner-Taylor CM; Galarza-Delgado DA
Rheumatology (Oxford); 2021 Mar; 60(3):1570-1571. PubMed ID: 32949132
[No Abstract] [Full Text] [Related]
7. Palisaded neutrophilic granulomatous dermatitis associated with systemic lupus erythematosus presenting with the burning rope sign.
Gulati A; Paige D; Yaqoob M; Proby CM; Cerio R; Harwood CA
J Am Acad Dermatol; 2009 Oct; 61(4):711-4. PubMed ID: 19577332
[TBL] [Abstract][Full Text] [Related]
8. Palisaded neutrophilic and granulomatous dermatitis in association with sarcoidosis.
Mahmoodi M; Ahmad A; Bansal C; Cusack CA
J Cutan Pathol; 2011 Apr; 38(4):365-8. PubMed ID: 20528967
[TBL] [Abstract][Full Text] [Related]
9. Palisaded neutrophilic granulomatous dermatitis presenting as an unusual skin manifestation in a patient with Behçet's disease.
Kim SK; Park CK; Park YW; Jun JB; Yoo DH; Bae SC
Scand J Rheumatol; 2005; 34(4):324-7. PubMed ID: 16195168
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with intralesional triamcinolone and oral dapsone for management of palisaded neutrophilic and granulomatous dermatitis.
He Y; Maverakis E; Ramirez-Maverakis D; Fitzmaurice S
Dermatol Online J; 2013 Feb; 19(2):17. PubMed ID: 23473287
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
12. Palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus: possible involvement of CD163
Terai S; Ueda-Hayakawa I; Nguyen CTH; Ly NTM; Yamazaki F; Kambe N; Son Y; Okamoto H
Lupus; 2018 Dec; 27(14):2220-2227. PubMed ID: 30376790
[TBL] [Abstract][Full Text] [Related]
13. Early lesion of palisaded neutrophilic granulomatous dermatitis in ulcerative colitis.
Asahina A; Fujita H; Fukunaga Y; Kenmochi Y; Ikenaka T; Mitomi H
Eur J Dermatol; 2007; 17(3):234-7. PubMed ID: 17483043
[TBL] [Abstract][Full Text] [Related]
14. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease.
Chu P; Connolly MK; LeBoit PE
Arch Dermatol; 1994 Oct; 130(10):1278-83. PubMed ID: 7944509
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.
Toussirot E; Berthelot JM; Pertuiset E; Bouvard B; Gaudin P; Wendling D; le Noach J; Lohse A; Lecuyer E; Cri L
J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509
[TBL] [Abstract][Full Text] [Related]
16. Palisaded neutrophilic granulomatous dermatitis with leukocytoclastic vasculitis in a patient without any underlying systemic disease detected to date.
Misago N; Shinoda Y; Tago M; Narisawa Y
J Cutan Pathol; 2010 Oct; 37(10):1092-7. PubMed ID: 19903215
[TBL] [Abstract][Full Text] [Related]
17. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
[TBL] [Abstract][Full Text] [Related]
18. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
Richez C; Blanco P; Gin H; Schaeverbeke T
Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936
[No Abstract] [Full Text] [Related]
19. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
Burmester GR; Mariette X; Montecucco C; Monteagudo-Sáez I; Malaise M; Tzioufas AG; Bijlsma JW; Unnebrink K; Kary S; Kupper H
Ann Rheum Dis; 2007 Jun; 66(6):732-9. PubMed ID: 17329305
[TBL] [Abstract][Full Text] [Related]
20. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
